Interleukin‐1 as a pharmacological target in acute brain injury

Publisher： John Wiley & Sons Inc

E-ISSN： 1469-445x|100|12|1488-1494

ISSN： 0958-0670

Source： EXPERIMENTAL PHYSIOLOGY (ELECTRONIC), Vol.100, Iss.12, 2015-12, pp. : 1488-1494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multifaceted roles for astrocytes in spreading depolarization: A target for limiting spreading depolarization in acute brain injury?

By  

GLIA, Vol. 64, Iss. 1, 2016-01 ,pp. : 5-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐1α and brain inflammation

By  

IUBMB LIFE, Vol. 67, Iss. 5, 2015-05 ,pp. : 323-330

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exogenous interleukin‐10 attenuates hyperoxia‐induced acute lung injury in mice

By  

EXPERIMENTAL PHYSIOLOGY (ELECTRONIC), Vol. 100, Iss. 3, 2015-03 ,pp. : 331-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Endothelial dysfunction in acute brain injury and the development of cerebral ischemia

By  

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 6, 2015-06 ,pp. : 866-872

John Wiley & Sons Inc

Access to resources Recommend Favorite

Endogenous Nitric-Oxide Synthase Inhibitor ADMA after Acute Brain Injury

By Jung Carla S.   Wispel Christian   Zweckberger Klaus   Beynon Christopher   Hertle Daniel   Sakowitz Oliver W.   Unterberg Andreas W.  

International Journal of Molecular Sciences, Vol. 15, Iss. 3, 2014-03 ,pp. : 4088-4103

MDPI

Access to resources Recommend Favorite